Hankook Korus said Monday that it would build four full sets of 1000-liter bioreactors to speed up manufacturing the Sputnik V vaccine developed by Russia’s Gamaleya Research Institute of Epidemiology and Microbiology.The company decided to install the bioreactors after securing the core culturing a
Roche Korea said it obtained local approval for Enspryng (ingredient: satralizumab), a treatment for neuromyelitis optical spectrum disorder (NMOSD), on Sunday.With the marketing nod, Enspryng will compete against Alexion’s Soliris (eculizumab), which won the license for NMOSD treatment recently.Ens
MSD Korea branch of the Korea Democratic Pharmaceutical Union (KDPU) said it has begun the procedure for dissolution less than three years after becoming the 17th KDPU branch in November 2018.Accordingly, the other representative bargaining unit will be the only labor union at MSD Korea.The MSD Kore
Genexine said Tuesday that Indonesian pharmaceutical company Kalbe Farma has pre-ordered 10 million doses of its Covid-19 vaccine candidate, GX-19N.Kalbe Farma will distribute Genexine's vaccine in the Southeast Asian country and pay royalties for the sales. Genexine plans to manufacture the vaccine
GE Healthcare Korea said Monday that it has confirmed excellent efficacy and safety of its magnetic resonance imaging (MRI) contrast agent, Clariscan, in the first study conducted in Korea and Asia.The company confirmed that more than 99.6 percent of 1,376 participants showed excellent or good quali
Samsung Biologics said Monday that it has agreed to scale up the initially agreed manufacturing deal of the U.S. biopharmaceutical company TG Therapeutics’ monoclonal antibody TG-1101 (ingredient: ublituximab) for blood cancer.Under the rearrangement, Samsung Biologics will increase the production o
Pfizer Pharmaceutical Korea said that Ibrance (ingredient name: Palbociclib) confirmed the treatment effect and safety profile in Korean patients regardless of menopause through a sub-analysis of its phase 3 PALOMA-3 study. This subgroup analysis, conducted on 43 Korean patients with advanced or pos
MSD Korea recently revised product briefing rules and announced that it would thoroughly monitor external meetings between its drug sales representatives and physicians.Earlier, the company expanded the Self-Assurance Program (SAP), recording doctors' conversations at a product briefing as part of i
“Local branches of global pharmaceutical companies persuaded their headquarters to supply Covid-19 vaccines to Korea quickly and made every effort to work with the government to secure vaccines.”Oh Dong-wook, country manager of Pfizer Korea who took office as chairman of the Korean Research-based Ph
GC Pharma said Monday that it has begun supplying HugPEG, an injection aid for Neulapeg (ingredient: pegteograstim), to neutropenia patients who have to administer the drug themselves.HugPEG allows users to attach and administer the pre-filled syringe combined with a needle guard, unlike the existin
Celltrion said that it has completed administering Regkirona (ingredient: Regdanvimab), its Covid-19 treatment, to 1,300 patients participating in its phase 3 global clinical trial.The company has been conducting phase 3 clinical trials in 13 countries, including Korea, the U.S., Spain, and Romania,
Bayer AG intends to make cell and gene therapy their future growth engine, according to an executive of the multinational drugmaker’s Korean offshoot.The chemical and biologics expertise the global pharmaceutical company has accumulated over its 157-year history led the company to become a powerhous
Korea’s shingles vaccine market braces up for a major change, as GSK plans to launch its shingles vaccine Shingrix, which boasts far higher efficacy than existing products, industry watchers said Friday.GSK applied for Shingrix's sales approval to the Ministry of Food and Drug Safety in January and
Samyang Holdings said that it has signed a contract MCurex, a subsidiary of Olix Pharmaceutical, to co-develop an mRNA (messenger ribonucleic acid) Covid-19 vaccine.Under the accord, the two companies will develop a drug delivery system that reliably delivers the vaccine to cells using mRNA, which c
Janssen Korea said that the government would provide health insurance benefits for its palmoplantar pustulosis treatment Tremfya (ingredient: Guselkumab) starting next month.Tremfya has become Korea's first and only biological treatment with reimbursement for patients with palmoplantar pustulosis.Pa
Huons Lab said Tuesday that it would develop a biosimilar of the osteoporosis drug, Prolia (ingredient: denosumab), with PanGen Biotech’s cell line culturing and purification technology.Under the accord, PanGen Biotech will transfer related technology to Huons Lab to develop antibody treatment for o
Roche said that the Ministry of Food and Drug Safety has approved an expanded indication for Tecentriq, its immunotherapy drug, as the first-line treatment of non-small cell lung cancer (NSCLC).Hospitals can now use the drug in treating patients with metastatic non-small cell lung cancer (NSCLC) wit
The Ministry of Food and Drug Safety punished Kolmar Pharma for using unauthorized additives to produce an orlistat-containing obesity drug last year.However, the mishap is still causing trouble for pharmaceutical companies that consigned the production of orlistat to Kolmar Pharma.The ministry has
Zuellig Pharma Solutions Service Korea (SSK) is suspected of enforcing early retirement or layoff on the SSK unionists in retaliation for striking, violating collective agreements with the Korea Democratic Pharmaceutical Union (KDPU).On Monday, the KDPU said all workers dismissed from SSK would file
GC Pharma said Tuesday that the company has confirmed the safety and efficacy of its neutropenia therapy for solid cancer, Neulapeg (ingredient: pegteograstim), in the four-year post-market surveillance (PMS).The company analyzed the PMS of 611 patients with solid cancer, including blood and breast